Home / News / India News / Article /
Drug regulator DCGI gives nod for conducting study on mixing Covaxin and Covishield
Updated On: 11 August, 2021 11:17 AM IST | New Delhi | mid-day online correspondent
This study will be different from the one by the Indian Council of Medical Research (ICMR) that revealed that the combination of Covaxin and Covishield vaccines, conducted on 18 people, has elicited better safety and immunogenicity results
Photo used for representational purpose
The Drugs Controller General of India (DCGI) has given nod for conducting a study on mixing Covaxin and Covishield, the two main vaccines of the Covid-19 vaccination programme in India.
A Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO) had recommended conducting the study on July 29.
How do you like the new new mid-day.com experience? Share your feedback and help us improve.
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT